Pulmonary hypertension management in neonates

被引:9
作者
Pandya, Kartikey A. [1 ]
Puligandla, Pramod S. [1 ,2 ]
机构
[1] Montreal Childrens Hosp, Div Pediat Gen & Thorac Surg, Montreal, PQ H3H 1P3, Canada
[2] Montreal Childrens Hosp, Div Pediat Crit Care Med, Montreal, PQ H3H 1P3, Canada
关键词
Pulmonary hypertension; Neonate; Pulmonary vascular resistance; Pulmonary vascular endothelium; Pulmonary vasodilators; INHALED NITRIC-OXIDE; CONGENITAL DIAPHRAGMATIC-HERNIA; INTRAVENOUS SILDENAFIL; MILRINONE; INFANTS; DISEASE; NEWBORN; LAMBS; HEMODYNAMICS; VASODILATOR;
D O I
10.1053/j.sempedsurg.2014.11.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The management of pulmonary hypertension is multi-faceted, with therapies directed at supporting cardiovascular and pulmonary function, treating the underlying cause (if feasible), and preventing irreversible remodeling of the pulmonary vasculature. Recently, manipulation of signaling pathways and mediators contained within the pulmonary vascular endothelial cell has become a new target. This article will review the pathophysiology of pulmonary hypertension and the broad principles involved in its management, with specific emphasis on pharmacological therapies directed at the pulmonary vascular endothelium. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:12 / 16
页数:5
相关论文
共 37 条
  • [1] L-Citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets
    Ananthakrishnan, Madhumita
    Barr, Frederick E.
    Summar, Marshall L.
    Smith, Heidi A.
    Kaplowitz, Mark
    Cunningham, Gary
    Magarik, Jordan
    Zhang, Yongmei
    Fike, Candice D.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2009, 297 (03) : L506 - L511
  • [2] [Anonymous], 1998, EXECUTIVE SUMMARY WO
  • [3] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
    Badesch, DB
    Tapson, VF
    McGoon, MD
    Brundage, BH
    Rubin, LJ
    Wigley, FM
    Rich, S
    Barst, RJ
    Barrett, PS
    Kral, KM
    Jöbsis, MM
    Loyd, JE
    Murali, S
    Frost, A
    Girgis, R
    Bourge, RC
    Ralph, DD
    Elliott, CG
    Hill, NS
    Langleben, D
    Schilz, RJ
    McLaughlin, VV
    Robbins, IM
    Groves, BM
    Shapiro, S
    Medsger, TA
    Gaine, SP
    Horn, E
    Decker, JC
    Knobil, K
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 425 - +
  • [4] Barst RJ, 2014, CIRCULATION, V113
  • [5] Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn
    Chambers, CD
    Hernandez-Diaz, S
    Van Marter, LJ
    Werler, MM
    Louik, C
    Jones, KL
    Mitchell, AA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) : 579 - 587
  • [6] Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension
    Deb, B
    Bradford, K
    Pearl, RG
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (03) : 795 - 799
  • [7] Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy
    Ferdman, Dina J.
    Rosenzweig, Erika B.
    Zuckerman, Warren A.
    Krishnan, Usha
    [J]. PEDIATRICS, 2014, 134 (01) : E274 - E278
  • [8] Field D, 1996, LANCET, V348, P75
  • [9] INHALED NITRIC-OXIDE IN INFANTS REFERRED FOR EXTRACORPOREAL MEMBRANE-OXYGENATION - DOSE-RESPONSE
    FINER, NN
    ETCHES, PC
    KAMSTRA, B
    TIERNEY, AJ
    PELIOWSKI, A
    RYAN, CA
    [J]. JOURNAL OF PEDIATRICS, 1994, 124 (02) : 302 - 308
  • [10] Neonatal extracorporeal life support: Impact of new therapies on survival
    Fliman, Paola J.
    DeRegnier, Raye-Ann O.
    Kinsella, John P.
    Reynolds, Marleta
    Rankin, Linda L.
    Steinhorn, Robin H.
    [J]. JOURNAL OF PEDIATRICS, 2006, 148 (05) : 595 - 599